C24H22FN3O6
Neat
467.46
874638-94-5; (2R, 3R, 4R, 5S)-5-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate; [(2R, 3R, 4R, 5S)-5-(4-benzamido-2-oxopyrimidin-1-yl)-3-benzoyloxy-4-fluoro-4-methyloxolan-2-yl]methyl benzoate; C31H26FN3O7; MFCD27918668; Sofosbuvir Impurity X; (2R, 3R, 4R, 5S)-5-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-2-(benzoyloxymethyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate; J83RKP6K2M; SCHEMBL14172900; CS-M2820; AKOS027255140; Sofosbuvir Dibenzoyl Amino alpha-Isomer; CS-14809; DB-246864; I11632; (2R, 3R, 4R, 5S)-5-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-ylbenzoate; [(2R, 3R, 4R, 5S)-5-(4-benzamido-2-oxo-pyrimidin-1-yl)-3-benzoyloxy-4-fluoro-4-methyl-tetrahydrofuran-2-yl]methyl benzoate; 5-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate, (2R, 3R, 4R, 5S)-; Benzamide, N-[1-[(2R)-3, 5-di-O-benzoyl-2-deoxy-2-fluoro-2-methyl-alpha-D-erythro-pentofuranosyl]-1, 2-dihydro-2-oxo-4-pyrimidinyl]; N-[1-[(2R)-3, 5-Di-O-benzoyl-2-deoxy-2-fluoro-2-methyl-alpha-D-erythro-pentofuranosyl]-1 and 2-dihydro-2-oxo-4-pyrimidinyl]benzamide
[(2R, 3R, 4R and 5S)-5-(4-benzamido-2-oxopyrimidin-1-yl)-3-benzoyloxy-4-fluoro-4-methyloxolan-2-yl]methyl benzoate
InChI=1S/C31H26FN3O7/c1-31(32)25(42-28(38)22-15-9-4-10-16-22)23(19-40-27(37)21-13-7-3-8-14-21)41-29(31)35-18-17-24(34-30(35)39)33-26(36)20-11-5-2-6-12-20/h2-18,23,25,29H,19H2,1H3,(H,33,34,36,39)/t23-,25-,29+,31-/m1/s1